<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01111214</url>
  </required_header>
  <id_info>
    <org_study_id>0887X1-4434</org_study_id>
    <secondary_id>B1841010</secondary_id>
    <nct_id>NCT01111214</nct_id>
  </id_info>
  <brief_title>Child Pneumococcal Serotype Epidemiology In Greece</brief_title>
  <official_title>Incidence And Serotypes Of Invasive Pneumococcal Disease, After The Introduction Of The Heptavalent Conjugated Vaccine In Greece</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Streptococcus pneumoniae is a major cause of pneumonia, sepsis, bacteremia, and pneumococcal
      meningitis among infants and children worldwide. The 7-valent conjugate pneumococcal vaccine
      (Prevenar) has been introduced in the Greek Market in 2004. Additionally, as of 2006 Prevenar
      has been included in the Greek National Immunization Program.

      The effect of the mass vaccination on the incidence of pneumococcal serotypes involved in the
      occurring invasive pneumococcal disease, is an important factor to consider for the
      introduction of the 13-valent pneumococcal conjugate vaccine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      open label, one group Purposive sampling of hospitalized children ≤14 years of age with
      confirmed IPD
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The serotype distribution of invasive S. pneumoniae isolates of hospitalized children up to 14 years of age after the introduction of the 7-valent conjugate pneumococcal vaccine</measure>
    <time_frame>yearly</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serotype distribution of resistant S. pneumoniae isolates</measure>
    <time_frame>yearly</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serotype distribution of IPD between immunized and non immunized children ≤14 years of age</measure>
    <time_frame>yearly</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antimicrobial susceptibilities of IPD isolates and rates of resistance to penicillin</measure>
    <time_frame>yearly</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">457</enrollment>
  <condition>Pneumococcal Disease</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <description>Hospitalized children ≤14 years of age with invasive pneumococcal disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>There is no intervention. This is a non interventional study.</description>
    <arm_group_label>group 1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized children in participating centers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 14 years old or less.

          -  Hospitalized in a participating healthcare facility with an IPD.

          -  IPD will be confirmed by isolation of S. pneumoniae from a sterile body site.

        Exclusion Criteria:

          -  Children &gt; 14 years of age

          -  Unconfirmed IPD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Agia Sophia Children's Hospital</name>
      <address>
        <city>Athens</city>
        <state>Attiki</state>
        <zip>115 27</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Alexandroupolis</name>
      <address>
        <city>Alexandroupoli</city>
        <zip>68100</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Herakleion</name>
      <address>
        <city>Herakleion</city>
        <zip>70013</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Venizeleion General Hospital of Herakleion</name>
      <address>
        <city>Herakleion</city>
        <zip>71409</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Ioannina</name>
      <address>
        <city>Ioannina</city>
        <zip>45332</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Thessaly School of Medicine</name>
      <address>
        <city>Larissa</city>
        <zip>415 00</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ahepa Hospital Paediatric Outpatient Special Clinic 1st Kyri</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54636</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ippokrateion Peripheral Hospital of Thessaloniki</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54642</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peripheral Hospital of Trikala</name>
      <address>
        <city>Trikala</city>
        <zip>42100</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=0887X1-4434&amp;StudyName=Child%20Pneumococcal%20Serotype%20Epidemiology%20In%20Greece</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2010</study_first_submitted>
  <study_first_submitted_qc>April 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2010</study_first_posted>
  <last_update_submitted>January 9, 2013</last_update_submitted>
  <last_update_submitted_qc>January 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Invasive Pneumococcal Disease (IPD)</keyword>
  <keyword>pneumococcal serotypes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumococcal Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

